M&A Deal Summary

CooperSurgical Acquires AEGEA Medical

On February 2, 2021, CooperSurgical acquired medical products company AEGEA Medical

Acquisition Highlights
  • This is CooperSurgical’s 9th transaction in the Medical Products sector.
  • This is CooperSurgical’s 9th transaction in the United States.
  • This is CooperSurgical’s 1st transaction in California.

M&A Deal Summary

Date 2021-02-02
Target AEGEA Medical
Sector Medical Products
Buyer(s) CooperSurgical
Deal Type Add-on Acquisition

Target

AEGEA Medical

Menlo Park, California, United States
AEGEA Medical provides an application for its water vapor ablation technology to deliver therapies that provide high-quality patient outcomes to a wider range of women. AEGEA’s FDA approved Mara Water Vapor Ablation System enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. Founded in 2008, AEGEA Medical is located in Menlo Park, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CooperSurgical

Trumbull, Connecticut, United States

Category Company
Founded 1990
Sector Medical Products
DESCRIPTION

CooperSurgical, Inc. is a developer of surgical medical products.


DEAL STATS #
Overall 13 of 13
Sector: Medical Products M&A 9 of 9
Type: Add-on Acquisition M&A Deals 9 of 9
State: California M&A 1 of 1
Country: United States M&A 9 of 9
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-11 Teva Pharmaceutical Industries - PARAGARD

Buffalo, New York, United States

PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.

Buy $1.1B